Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Finasteride vs Minoxidil in Androgenetic Alopecia
NCT06826001Phase 2Not yet recruiting
- Sponsor
- Sheikh Zayed Medical College
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of DA-4001C in androgenetic alopecia (AGA) (2 arms), sponsored by Sheikh Zayed Medical College. Primary endpoint: Comparison of Efficacy of Topical Finasteride Versus Topical Minoxidil in Treatment of Androgenetic Alopecia at 6 months. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
DA-4001C
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06826001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06826001.